Singh Dewasya Pratap, Awasthi Harshika, Luqman Suaib, Singh Saudan, Mani Dayanandan
Department of Herbal Medicinal Products, CSIR-Central Institute of Medicinal and Aromatic Plants, Lucknow - 226 015, Uttar Pradesh, India.
Molecular Bioprospection Department, CSIR-Central Institute of Medicinal and Aromatic Plants, Lucknow - 226 015, Uttar Pradesh, India; Academy of Scientific and Innovative Research, CSIR-Central Institute of Medicinal and Aromatic Plants, Lucknow - 226 015, Uttar Pradesh, India.
Pharmacogn Mag. 2015 Oct;11(Suppl 3):S375-9. doi: 10.4103/0973-1296.168945.
Traditionally, a number of medicinal plants are used to treat various types of hepatic disorders but few of them were pharmacologically evaluated for their safety and efficacy. The combination of Andrographis paniculata (Kalmegha), Tinospora cordifolia (Guduchi), and Solanum nigrum (Kakmachi) was traditionally used in Indian System of Medicine (Ayurveda) for the treatment of various liver-related disorders.
In the present study, an attempt was made to substantiate the ethnopharmacological use of a traditional formulation in hepatoprotection against paracetamol-induced hepatotoxicity.
Swiss albino mice (weight 20-25 g) were used for this study. Intraperitoneal injection of paracetamol (500 mg/kg body weight) was used to induce hepatotoxicity. Serum levels of alanine transaminase, aspartate aminotransferase, bilirubin, alkaline phosphatase, were used as indices of liver injury. In addition total cholesterol, triglyceride, low-density lipoprotein, high-density lipoprotein and creatinine were also assayed using the standard procedure.
Among the two different doses, pretreatment with Polyherbal extract at 500 mg/kg body weight exhibited a significant (P < 0.05) hepatoprotective activity as compared to paracetamol group.
The polyherbal extract exhibits a significant hepatoprotective effect in vivo. The study contributes to its use in traditional Ayurveda system for the management of liver diseases.
Traditionally, a number of medicinal plants are used to treat various types of liver disorders but few of them were pharmacologically evaluated for their safety and efficacy. Combination of Andrographis paniculata (Kalmegha), Tinospora cordifolia (Guduchi), and Solanum nigrum (Kakmachi) was traditionally used in Ayurveda for the treatment of various liver related disorders. In the present study an attempt was made to validate the ethnopharmacological use of a traditional formulation in hepatoprotection against paracetamol induced hepatotoxicity. Swiss albino mice (weight 20-25 g) were used for this study. Intraperitoneal injection (IP) of paracetamol (500 mg/kg body weight) was used to induce hepatotoxicity. Serum levels of Alanine transaminase (ALT), Aspartate Aminotransferase (AST), Bilirubin, Alkaline phosphatase (ALP),. were used as indices of liver injury. In addition total cholesterol, triglyceride, Low density lipoprotein (LDL), High density lipoprotein (HDL) and creatinine were also assayed using standard procedure. Among the two different doses, pre-treatment with Polyherbal extract at 500 mg/kg body weight exhibited a significant (P < 0.05) hepatoprotective activity as compared to paracetamol group. The polyherbal extract exhibits significant hepatoprotective effect in vivo. The study contributes to its use in traditional Ayurveda system for the management of liver diseases.
传统上,许多药用植物被用于治疗各种类型的肝脏疾病,但其中很少有经过药理学评估其安全性和有效性的。穿心莲(Kalmegha)、匙叶翼首草(Guduchi)和龙葵(Kakmachi)的组合在印度医学体系(阿育吠陀)中传统上用于治疗各种与肝脏相关的疾病。
在本研究中,试图证实一种传统配方在保护肝脏免受对乙酰氨基酚诱导的肝毒性方面的民族药理学应用。
本研究使用瑞士白化小鼠(体重20 - 25克)。腹腔注射对乙酰氨基酚(500毫克/千克体重)以诱导肝毒性。血清丙氨酸转氨酶、天冬氨酸转氨酶、胆红素、碱性磷酸酶水平用作肝损伤指标。此外,还使用标准程序测定总胆固醇、甘油三酯、低密度脂蛋白、高密度脂蛋白和肌酐。
在两种不同剂量中,与对乙酰氨基酚组相比,以500毫克/千克体重的多草药提取物预处理表现出显著(P < 0.05)的肝保护活性。
多草药提取物在体内表现出显著的肝保护作用。该研究有助于其在传统阿育吠陀体系中用于肝脏疾病的管理。
传统上,许多药用植物被用于治疗各种类型的肝脏疾病,但其中很少有经过药理学评估其安全性和有效性的。穿心莲(Kalmegha)、匙叶翼首草(Guduchi)和龙葵(Kakmachi)的组合在阿育吠陀中传统上用于治疗各种与肝脏相关的疾病。在本研究中,试图验证一种传统配方在保护肝脏免受对乙酰氨基酚诱导的肝毒性方面的民族药理学应用。本研究使用瑞士白化小鼠(体重20 - 25克)。腹腔注射(IP)对乙酰氨基酚(500毫克/千克体重)以诱导肝毒性。血清丙氨酸转氨酶(ALT)、天冬氨酸转氨酶(AST)、胆红素、碱性磷酸酶(ALP)水平用作肝损伤指标。此外,还使用标准程序测定总胆固醇、甘油三酯、低密度脂蛋白(LDL)、高密度脂蛋白(HDL)和肌酐。在两种不同剂量中,与对乙酰氨基酚组相比,以500毫克/千克体重的多草药提取物预处理表现出显著(P < 0.05)的肝保护活性。多草药提取物在体内表现出显著的肝保护作用。该研究有助于其在传统阿育吠陀体系中用于肝脏疾病的管理。